| IHS | idiopathic hypereosinophilic syndrome; inactivated horse serum; Indian Health Service; integrated he... |
|---|---|
| MCH | Maternal and Child Health; mean corpuscular hemoglobin; muscle contraction headache |
| MIH | Master of Industrial Health; migraine with interval headache; minimal intermittent heparin [dose] |
| OFHA | occipitofrontal headache |
| PDPH | postdural puncture headache |
| PBD | Peroxisome biogenesis disorders |
|---|---|
| PT-LPDs | Post-transplantation lymphoproliferative disorders |
| SADS-L | Schedule for Affective Disorders and Schizophrenia Lifetime Version |
| SRBD | Sleep-Related Breathing Disorders |
| SCID II | Structured Clinical Interview for DSM-III-R Personality Disorders |
| sexual and gender disorders | Mental disorders related to sexual dysfunction, paraphillias, and gender identity disorders. (12 Dec 1998) |
|---|---|
| sleep disorders | Disturbances of usual sleep patterns or behaviours. (12 Dec 1998) |
| social behaviour disorders | Behaviours which are at variance with the expected social norm and which affect other individuals. (12 Dec 1998) |
| somatoform disorders | Disorders having the presence of physical symptoms that suggest a general medical condition and that are not fully explained by a general medical condition, by the direct effects of a substance, or by another mental disorder. The symptoms must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to factitious disorders and malingering, the physical symptoms are not under voluntary control. (12 Dec 1998) |
| speech disorders | Long-term disorders in speaking or in perception of speech. (12 Dec 1998) |
| necrobiotic disorders | A group of disorders characterised by swelling, basophilia, and distortion of collagen bundles in the dermis. (12 Dec 1998) |
| neurotic disorders | Disorders in which the symptoms are distressing to the individual and recognised by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment. (12 Dec 1998) |
| stress disorders, posttraumatic | Anxiety disorders manifested by the development of characteristic symptoms following a psychologically traumatic event that is outside the normal range of usual human experience. Symptoms include re-experiencing the traumatic event and numbing of responsiveness to or reduced involvement with the external world. (12 Dec 1998) |
| substance abuse disorders | A class of mental disorders in which behavioural and biological changes are associated with regular use of alcohol, drugs, and related substances that affect the central nervous system and personal and social functioning. (05 Mar 2000) |
| substance-induced organic mental disorders | Mental disorders caused by use of drugs, e.g., cocaine. (05 Mar 2000) |
| substance-related disorders | These non-psychotic disorders include those related to the taking of a drug of abuse (including alcohol), to the side effects of a medication, and to toxin exposure. (12 Dec 1998) |
| delirium, dementia, amnestic, cognitive disorders | Cognitive disorders including delirium, dementia, and other cognitive disorders. These may be the result of substance use, trauma, or other causes. (12 Dec 1998) |
| disorders, myeloproliferative | Tumours of certain bone marrow cells including those that give rise to red cells, granulocytes, and platelets. As opposed to the lymphoproliferative disorders. (12 Dec 1998) |
| dissociative disorders | Sudden temporary alterations in the normally integrative functions of consciousness. (12 Dec 1998) |
| immunodeficiency disorders | <radiology> B-cell (antibody) deficiency: high-grade pathogens: pneumococcus, strep, H. Flu, chronic sinopulmonary disease, usual survival to adulthood, T-cell (cellular) deficiency: low-grade pathogens: fungi, viruses, Pneumocystic, growth retardation, diarrhoea, delayed anergy, short life-span, susceptible to graft vs. Host (GvH) disease, e.g.: DiGeorge syndrome, Nezelhof syndrome Note: increased risk of malignancy (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|